AI-generated summary
The authors review brain-computer interface and closed-loop-relevant evidence in Alzheimer's disease and mild cognitive impairment, organizing the field around sensing, decoding, intervention, target engagement and safety. They report that reliable decoding of waking cognitive states, broader controller utility and durable clinical benefit remain unvalidated. The review proposes a translational research agenda rather than evaluating any treatment's efficacy.
- Who or what was studied
- Individuals with Alzheimer's disease or mild cognitive impairment
- Limits stated in the abstract
- This is a targeted narrative review, and the abstract states that reliable waking-state decoding and durable clinical benefit remain unvalidated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on aginganddisease.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Functional magnetic resonance imaging, Functional near-infrared spectroscopy, Transcranial photobiomodulation, Mild cognitive impairment, Electroencephalography, Transcranial direct current stimulation, Transcranial magnetic stimulation, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.